March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...